Scotiabank raised the firm’s price target on Omega Healthcare (OHI) to $42 from $39 and keeps a Sector Perform rating on the shares. The firm is updating its price targets on stocks in the U.S. Real Estate & REITs sector under its coverage following Q2 results, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- MedaSync announces strategic investment from Omega Healthcare
- Omega Healthcare Investors Reports Strong Q2 2025 Results
- Omega Healthcare Investors’ Earnings Call Highlights Robust Growth
- Omega Healthcare’s Strong Q2 Performance and Strategic Moves Justify Buy Rating
- Omega Healthcare reports Q2 adjusted FFO 77c, consensus 76c